N-phenylureas
eMolecules Medchem Express / SB 452533 / 5mg / 686240126 / HY-108458 / / 459429-39-1 / MFCD19690909 / 376.298 / C18H22BrN3O
Medchem Express / SB 452533 / 5mg / 686240126 / HY-108458 / / 459429-39-1 / MFCD19690909 / 376.298 / C18H22BrN3O
Medchemexpress LLC 1-phenylurea | 64-10-8 | MFCD00007944 | 99.9% | 136.15 g/mol | C7H8N2O | 1 KG
1-Phenylurea is an organic phenylurea compound used as a research reagent and building block in synthetic chemistry and biochemical assays. It is provided in research-grade purity for laboratory applications.
- High purity suitable for research-grade applications (reported 99.85%).
- Chemical formula C7H8N2O; molecular weight 136.15 g/mol.
- Commonly used as a building block in organic synthesis and as a reagent in biochemical assays.
- Identified by CAS number 64-10-8 for unambiguous reference.
- Supplied in formats appropriate for routine laboratory handling and storage.
Medchemexpress LLC 1-Phenylurea | 64-10-8 | MFCD00007944 | 99.9% | 136.15 g/mol | C7H8N2O | 500 G
1-Phenylurea is an organic small molecule (C7H8N2O, CAS 64-10-8) supplied as a high-purity solid for laboratory research and biochemical assays. It has a molecular weight of 136.15 g/mol and is used as a reagent or reference compound in analytical and life-science workflows.
- High purity (~99.9%) suitable for research-grade applications.
- Solid form with defined molecular weight (136.15 g/mol) for accurate dosing.
- CAS-registered substance (CAS 64-10-8) for unambiguous identification.
- Available in larger pack sizes for bulk laboratory use.
- Applicable as a reagent, control, or reference in biochemical assays.
- Stable under typical storage conditions for solid organics.
Selleck Chemical LLC A939572-5mg
A939572 is a potent and orally bioavailable stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50 of <4 nM and 37 nM for mSCD1 and hSCD1, respectively.
eMolecules Medchem Express / SB-265610 / 5mg / 713705019 / HY-50688 / / 211096-49-0 / MFCD09971124 / 357.171 / C14H9BrN6O
Medchem Express / SB-265610 / 5mg / 713705019 / HY-50688 / / 211096-49-0 / MFCD09971124 / 357.171 / C14H9BrN6O
AA BLOCKS LLC 922925-46-0 | 6-(4-fluorophenyl)-2-[(pyridin-4-yl)methyl]-2,3-dihydropyridazin-3-one
6-(4-fluorophenyl)-2-[(pyridin-4-yl)methyl]-2,3-dihydropyridazin-3-one. 5 mg. CAS Number: 922925-46-0; Molecular Formula: C16H12FN3O
Medchemexpress LLC SB 452533 | 459429-39-1 | 99.1% | 376.29 g/mol | C18H22BrN3O | 5 MG
SB 452533 is a potent, selective TRPV1 antagonist supplied for research use. It is provided with analytical documentation and safety data suitable for pharmacological and preclinical studies of TRPV1-mediated signaling.
- Selective TRPV1 antagonist for receptor pharmacology studies.
- Purity 99.11%.
- Molecular weight 376.29 g/mol.
- Chemical formula C18H22BrN3O.
- White to off-white solid physical form.
- Supplied with COA, LCMS data, and SDS documentation.
- Soluble in DMSO for assay preparation.
eMolecules Ambeed / 4-Phenylsemicarbazide / 1g / 575774817 / A368588 / / 537-47-3 / MFCD00007590 / 151.169 / C7H9N3O
Ambeed / 4-Phenylsemicarbazide / 1g / 575774817 / A368588 / / 537-47-3 / MFCD00007590 / 151.169 / C7H9N3O
Medchemexpress LLC SB-265610 | 211096-49-0 | ≥99.0% | C14H9BrN6O | 5 MG
SB-265610 | 211096-49-0 | ≥99.0% | C14H9BrN6O | 5 MG
Medchemexpress LLC SB-265610 | 211096-49-0 | 98.98% | C14H9BrN6O | 50 MG
SB-265610 is a selective, competitive, nonpeptide, and allosteric CXCR2 antagonist. It blocks rat CINC-1-induced calcium mobilization (IC50 of 3.7 nM) and neutrophil chemotaxis (IC50 of 70 nM). In animal models, it significantly inhibits Gr-1+CD11b+ cell recruitment to mammary adenocarcinoma.
- Selective, competitive, nonpeptide, and allosteric CXCR2 antagonist.
- Blocks rat CINC-1-induced calcium mobilization (IC50 of 3.7 nM).
- Blocks neutrophil chemotaxis (IC50 of 70 nM).
- Reduces CINC-1's antiapoptotic effect.
- Inhibits Gr-1+CD11b+ cell recruitment to mammary adenocarcinoma in animal models.
Medchemexpress LLC 1-(2-bromophenyl)-3-(7-cyano-2H-benzotriazol-4-yl)urea | 211096-49-0 | MFCD09971124 | 699.0% | 357.16 g·mol⁻¹ | C14H9BrN6O | 10 MG
SB-265610 is a selective, competitive, nonpeptide, allosteric antagonist of the CXCR2 chemokine receptor used as a research reagent to study neutrophil chemotaxis and CXCR2-mediated signaling. It inhibits CINC-1-induced calcium mobilization (IC50 3.7 nM) and neutrophil chemotaxis (IC50 70 nM).
- Selective CXCR2 antagonist for receptor pharmacology studies.
- Reported low-nanomolar potency for calcium mobilization assays.
- Suitable for in vitro chemotaxis and signaling experiments.
- Supplied as a small-molecule solid for formulation or dosing control.
- Characterized by published analytical data and CAS registration for traceability.